Application 103948
- Type
- BLA
- Sponsor
- GENZYME
Purple Book Biologic Products#
| BLA | Proprietary name | Proper name | License type | Status | Latest source |
|---|---|---|---|---|---|
| 103948 | Campath | alemtuzumab | 351(a) | Disc | 2026-06-01 |
Application Products#
| Product | Drug | Ingredient | Form | Strength | Reference drug | Reference standard |
|---|---|---|---|---|---|---|
| 001 | CAMPATH | ALEMTUZUMAB | VIAL; INTRAVENOUS | 10MG/ML | No | No |
| 002 | CAMPATH | ALEMTUZUMAB | VIAL; INTRAVENOUS | 30MG/ML | No | No |
| 003 | LEMTRADA | ALEMTUZUMAB | INJECTABLE;INJECTION | 12MG/1.2ML (10MG/ML) | No | No |
openFDA label cross-check#
OpenFDA label data provides additional search and identifier links. DailyMed’s Structured Product Label is the canonical label on FDA.report. Matching records are deduplicated before they are shown below.
| Brand | Generic | Manufacturer | SPL set ID | Effective date | Available safety fields | Join |
|---|---|---|---|---|---|---|
| Campath | ALEMTUZUMAB | Genzyme Corporation | 4f5f7255-7abc-4328-bd1a-ceaf139ef3e0 | 2025-11-05 | Boxed warning, Warnings, Adverse reactions | BLA103948 58468-0357 |
| LEMTRADA | ALEMTUZUMAB | Genzyme Corporation | 6236b0bc-82e9-4447-9a78-f57d94770269 | 2025-11-03 | Boxed warning, Warnings, Adverse reactions | BLA103948 58468-0200 |
NDC Listings For This Application#
| NDC | Name | Nonproprietary name | Labeler | Marketing category | Status |
|---|---|---|---|---|---|
| 58468-0200 | LEMTRADA | ALEMTUZUMAB | Genzyme Corporation | BLA | Current |
| 58468-0200 | LEMTRADA | ALEMTUZUMAB | Genzyme Corporation | BLA | Current |
| 58468-0200 | LEMTRADA | ALEMTUZUMAB | Genzyme Corporation | BLA | Current |
| 58468-0200 | LEMTRADA | ALEMTUZUMAB | Genzyme Corporation | BLA | Current |
| 58468-0200 | LEMTRADA | ALEMTUZUMAB | Genzyme Corporation | BLA | Current |
| 58468-0200 | LEMTRADA | ALEMTUZUMAB | Genzyme Corporation | BLA | Current |
| 58468-0200 | LEMTRADA | ALEMTUZUMAB | Genzyme Corporation | BLA | Current |
| 58468-0200 | LEMTRADA | ALEMTUZUMAB | Genzyme Corporation | BLA | Current |
| 58468-0200 | LEMTRADA | ALEMTUZUMAB | Genzyme Corporation | BLA | Current |
| 58468-0200 | LEMTRADA | ALEMTUZUMAB | Genzyme Corporation | BLA | Current |
| 58468-0200 | LEMTRADA | ALEMTUZUMAB | Genzyme Corporation | BLA | Current |
| 58468-0200 | LEMTRADA | ALEMTUZUMAB | Genzyme Corporation | BLA | Current |
| 58468-0200 | LEMTRADA | ALEMTUZUMAB | Genzyme Corporation | BLA | Current |
| 58468-0200 | LEMTRADA | ALEMTUZUMAB | Genzyme Corporation | BLA | Current |
| 58468-0200 | LEMTRADA | ALEMTUZUMAB | Genzyme Corporation | BLA | Current |
| 58468-0357 | Campath | ALEMTUZUMAB | Genzyme Corporation | BLA | Current |
| 58468-0357 | Campath | ALEMTUZUMAB | Genzyme Corporation | BLA | Current |
| 58468-0357 | Campath | ALEMTUZUMAB | Genzyme Corporation | BLA | Current |
| 58468-0357 | Campath | ALEMTUZUMAB | Genzyme Corporation | BLA | Current |
| 58468-0357 | Campath | ALEMTUZUMAB | Genzyme Corporation | BLA | Current |
| 58468-0357 | Campath | ALEMTUZUMAB | Genzyme Corporation | BLA | Current |
| 58468-0357 | Campath | ALEMTUZUMAB | Genzyme Corporation | BLA | Current |
| 58468-0357 | Campath | ALEMTUZUMAB | Genzyme Corporation | BLA | Current |
| 58468-0357 | Campath | ALEMTUZUMAB | Genzyme Corporation | BLA | Current |
Documents#
| Document | Submission type | Date |
|---|---|---|
| 78542 | SUPPL | 2024-05-22 |
| 78541 | SUPPL | 2024-05-22 |
| 78522 | SUPPL | 2024-05-21 |
| 77713 | SUPPL | 2024-03-05 |
| 77463 | SUPPL | 2024-02-12 |
| 77446 | SUPPL | 2024-02-09 |
| 74105 | SUPPL | 2023-04-27 |
| 74095 | SUPPL | 2023-04-27 |
| 72171 | SUPPL | 2022-09-28 |
| 72166 | SUPPL | 2022-09-27 |
| 71194 | SUPPL | 2022-06-01 |
| 71193 | SUPPL | 2022-06-01 |
| 71162 | SUPPL | 2022-05-27 |
| 70451 | SUPPL | 2022-03-09 |
| 69889 | SUPPL | 2022-01-18 |
| 69882 | SUPPL | 2022-01-14 |
| 68424 | SUPPL | 2021-08-19 |
| 68423 | SUPPL | 2021-08-19 |
| 68410 | SUPPL | 2021-08-19 |
| 67383 | SUPPL | 2021-05-04 |
| 67382 | SUPPL | 2021-05-04 |
| 67257 | SUPPL | 2021-04-29 |
| 66784 | SUPPL | 2021-03-16 |
| 65027 | SUPPL | 2020-10-26 |
| 64990 | SUPPL | 2020-10-23 |
| 64746 | SUPPL | 2020-09-29 |
| 64745 | SUPPL | 2020-09-29 |
| 64744 | SUPPL | 2020-09-29 |
| 64733 | SUPPL | 2020-09-29 |
| 64732 | SUPPL | 2020-09-29 |
| 63768 | SUPPL | 2020-07-01 |
| 63756 | SUPPL | 2020-06-30 |
| 63341 | SUPPL | 2020-05-29 |
| 63340 | SUPPL | 2020-05-29 |
| 63333 | SUPPL | 2020-05-29 |
| 61115 | SUPPL | 2019-11-29 |
| 61074 | SUPPL | 2019-11-27 |
| 60735 | SUPPL | 2019-10-30 |
| 60734 | SUPPL | 2019-10-30 |
| 60733 | SUPPL | 2019-10-30 |
| 60732 | SUPPL | 2019-10-30 |
| 60716 | SUPPL | 2019-10-30 |
| 60715 | SUPPL | 2019-10-30 |
| 59559 | SUPPL | 2019-08-02 |
| 59536 | SUPPL | 2019-08-01 |
| 58427 | SUPPL | 2019-04-26 |
| 57678 | SUPPL | 2019-02-15 |
| 57303 | SUPPL | 2019-01-22 |
| 57238 | SUPPL | 2019-01-17 |
| 57237 | SUPPL | 2019-01-17 |
| 56822 | SUPPL | 2018-12-20 |
| 56805 | SUPPL | 2018-12-19 |
| 56804 | SUPPL | 2018-12-19 |
| 56619 | SUPPL | 2018-12-03 |
| 56618 | SUPPL | 2018-12-03 |
| 56606 | SUPPL | 2018-11-30 |
| 54913 | SUPPL | 2018-07-18 |
| 53951 | SUPPL | 2017-12-15 |
| 53952 | SUPPL | 2017-12-14 |
| 53977 | SUPPL | 2015-09-22 |
| 53950 | ORIG | 2015-07-02 |
| 53949 | ORIG | 2005-11-30 |
| 53948 | ORIG | 2005-09-13 |
| 53976 | SUPPL | 2004-05-19 |
| 53947 | ORIG | 2004-03-12 |
| 53946 | ORIG | 2004-03-12 |